Perinatal Opioid Exposure Primes the Peripheral Immune System Toward Hyperreactivity

Frontiers in Pediatrics
Jessie C NewvilleLauren L Jantzie

Abstract

The increased incidence of opioid use during pregnancy warrants investigation to reveal the impact of opioid exposure on the developing fetus. Exposure during critical periods of development could have enduring consequences for affected individuals. Particularly, evidence is mounting that developmental injury can result in immune priming, whereby subsequent immune activation elicits an exaggerated immune response. This maladaptive hypersensitivity to immune challenge perpetuates dysregulated inflammatory signaling and poor health outcomes. Utilizing an established preclinical rat model of perinatal methadone exposure, we sought to investigate the consequences of developmental opioid exposure on in vitro activation of peripheral blood mononuclear cells (PBMCs). We hypothesize that PBMCs from methadone-exposed rats would exhibit abnormal chemokine and cytokine expression at baseline, with exaggerated chemokine and cytokine production following immune stimulation compared to saline-exposed controls. On postnatal day (P) 7, pup PMBCs were isolated and cultured, pooling three pups per n. Following 3 and 24 h, the supernatant from cultured PMBCs was collected and assessed for inflammatory cytokine and chemokine expression at baseline...Continue Reading

References

Mar 1, 1979·Early Human Development·J Dobbing, J Sands
Apr 1, 1992·Archives of Disease in Childhood·N P DaviesK H Nicolaides
Feb 11, 1999·Journal of Neuroscience Research·R C VannucciS J Vannucci
Mar 10, 2001·Cytokine·O DammannUNKNOWN ELGAN STUDY INVESTIGATORS
Aug 3, 2001·Neuroscience·B ClancyB L Finlay
Feb 14, 2002·Mechanisms of Ageing and Development·Assia CatalaniFrancesco Amenta
Apr 18, 2003·Clinical and Experimental Immunology·K HasegawaS Furukawa
Dec 12, 2003·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Michael P HolsappleKenneth S Landreth
Feb 25, 2005·Behavioral Neuroscience·Staci D BilboSteven F Maier
Sep 2, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Staci D BilboSteven F Maier
Apr 26, 2007·Nature Reviews. Immunology·Luke A J O'Neill, Andrew G Bowie
Jan 15, 2008·Journal of Neuroscience Research·K H BockhorstJ R Perez-Polo
Aug 30, 2008·Pediatric Research·Alexander M TuckerMarianne Thoresen
Jun 27, 2009·Annual Review of Neuroscience·Arnold Kriegstein, Arturo Alvarez-Buylla
Jul 10, 2009·The Cochrane Database of Systematic Reviews·Richard P MattickMarina Davoli
Jan 12, 2010·American Journal of Reproductive Immunology : AJRI·Sally A Madsen-BouterseSorin Draghici
Jul 28, 2010·Clinical and Experimental Pharmacology & Physiology·Julian G AyerS Ben Freedman
Aug 10, 2010·Annals of Neurology·Chang-Yi LinChao-Ching Huang
Oct 12, 2010·The Cochrane Database of Systematic Reviews·David A OsbornMichael J Cole
Aug 13, 2011·Current Pharmaceutical Design·Weihong PanAbba J Kastin
Oct 18, 2011·The Journal of Pediatrics·T Michael O'SheaUNKNOWN Extremely Low Gestational Age Newborn (ELGAN) Study Investigators
Feb 1, 2012·Pediatrics·Mark L HudakUNKNOWN American Academy of Pediatrics
Mar 1, 2012·Neurology Research International·Claire ThorntonHenrik Hagberg
Apr 25, 2012·Neurology Research International·Ryan M McAdams, Sandra E Juul
May 2, 2012·JAMA : the Journal of the American Medical Association·Stephen W PatrickMatthew M Davis
May 16, 2012·Archives of Gynecology and Obstetrics·Emma GreigAbdel Douiri
May 23, 2012·Lancet Neurology·Bobbi Fleiss, Pierre Gressens

❮ Previous
Next ❯

Software Mentioned

Power
ARRIVE
GraphPad
Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.